(Adnkronos) - L’Istituto nazionale dei Tumori di Milano ha ospitato l’evento di presentazione della nuova edizione di ‘Fattore J’, un'iniziativa di Johnson & Johnson e Fondazione mondo digitale Ets che mira a sensibilizzare le giovani generazioni sul valore dell’innovazione nel campo della salute. Al centro dell’edizione 2024-2025 del progetto il ruolo dell'intelligenza artificiale nella creazione della medicina del futuro.
Category
🗞
NewsTranscript
00:00The role of artificial intelligence in the creation of medicine of the future is at the
00:08center of the fifth edition of Fattore J, the initiative of Johnson & Johnson and Fondazione
00:13Mondo Digitale TS that aims to raise awareness among young generations about the value of
00:17innovation in the field of health. As shown by the survey conducted by SVG for Johnson
00:23& Johnson, over 60% of young people of Generation Z believe that scientific research and medicine
00:29are the sectors that will benefit the most from artificial intelligence, towards which
00:33they nurture a deep trust, convinced that this technology will have a positive impact
00:37on the health of the future, making it faster, organized, effective and personalized.
00:43Fattore J is the fifth edition of our social responsibility project. As Johnson & Johnson
00:51we bring innovation in many ways, therapeutic innovation in clinical research, in development,
00:58but above all we want to take care of information. Information of the youngest, so we want
01:04with this project to try to build a bridge between the school and the world of health.
01:13It is clear that young people are certainly interested in this concept. We know, however,
01:19that we are surrounded by many new things, artificial intelligence that permeates our
01:24everyday reality and that transforms and will transform the world of health more and more.
01:29Already in its previous editions, the project involved a large number of students, institutions, associations.
01:35We have already trained 30,000 students, reached 300,000, in collaboration with 18 associations
01:42of patients, over 180 schools, 5 institutions, research institutes such as the National Institute
01:50of Tumors of Milan, which hosts us today, so a great ecosystem on the health of the country.
01:56Five, the elements that link technological innovation to oncology, as explained by the director
02:01of the National Institute of Tumors, of which scientific collaboration is endorsed by Fattore J.
02:05Four are the elements, prevention, screening, assistance, research. They are all four elements
02:13that have innovation, pharmacological technology and instruments within them. We add a fifth,
02:19artificial intelligence. I believe that artificial intelligence, and these guys on artificial intelligence
02:25will have their say, I believe it could be an additional element to exploit and use.